Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Kinled Holding

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 30
Average round size
The average size of a deal this fund participated in
Portfolio companies 28
Rounds per year 0.71
Lead investments 2
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 4
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Medical
  • Internet

In 1980 was created Kinled Holding, which is appeared as VC. The leading representative office of defined VC is situated in the New York. The fund was located in North America if to be more exact in United States.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - Switzerland. We can highlight the next thriving fund investment areas, such as Chemical, Crowdfunding. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight KB Medical, System1 Biosciences.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Kinled Holding, startups are often financed by Foundation for Technological Innovation (FIT), Venture Kick, Northwell Ventures. The meaningful sponsors for the fund in investment in the same round are Telor International, Northwell Ventures, KREAXI. In the next rounds fund is usually obtained by Telor International.

The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2017. Deals in the range of 1 - 5 millions dollars are the general things for fund. This Kinled Holding works on 12 percentage points less the average amount of lead investments comparing to the other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Kinled Holding:
Typical Co-investors
Kinled Holding is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Kinled Holding:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aligned Climate Capital New York, New York, United States
Chenghe Capital China, Hangzhou, Zhejiang
Conexus Credit Union Canada, Regina, Saskatchewan
Entrepia Ventures California, Santa Clara, United States
Financial 360 Investment -
Forebright Capital China, Guangdong, Shenzhen
Four Seasons Ventures District of Columbia, United States, Washington
GF Capital Management & Advisors New York, New York, United States
IHH Healthcare Berhad Kuala Lumpur, Malaysia
Jacobson Family Investments New York, New York, United States
Life Science Institute Japan, Tokyo
Shenzhenshi Xiaohe Chuangye Touzi China, Guangdong, Shenzhen
Tech Equity Partners Canada, Halifax, Nova Scotia
The Next Big Thing Foundation British Columbia, Canada, Vancouver
Udtara Ventures Delhi, India, New Delhi
University of Surrey Guildford, Surrey, United Kingdom
VIC Technology Venture Development Arkansas, Fayetteville, United States
WaterEquity Kansas City, Missouri, United States
ZenShin Capital California, Menlo Park, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Alentis Therapeutics

$65M15 Jun 2021 Basel, Basel-City, Switzerland

PreComb Therapeutics AG

Life Science
$2M27 Apr 2021 Hombrechtikon, Zurich, Switzerland

Eirion Therapeutics

Life Science
$40M09 Mar 2021 Woburn, Massachusetts, United States

Muse Finance

Financial Exchanges
Financial Services
$1M11 Feb 2021 London, England, United Kingdom


01 Jan 2021 London, England, United Kingdom

Araris Biotech

$16M22 Oct 2020 Zurich, Zurich, Switzerland


Real Estate Investment
$920K11 May 2020 London, England, United Kingdom


01 Jan 2020 NA - Isle of Man, Middle, Isle of Man

Aleva Neurotherapeutics

Health Care
Health Diagnostics
Medical Device
$8M16 Dec 2019 Lausanne, Vaud, Switzerland


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Kinled Holding?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: